Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1601
Intuitive Surgical
ISRG
$131B
| $6.52M | 0.01% |
53,619
-1,553,907
| -97% | -$194M |
|
|
CHCT
1602
Community Healthcare Trust
CHCT
$429M
| $6.52M | 0.01% |
232,008
-237,477
| -51% | -$6.57M |
|
1603
Pultegroup
PHM
$24.9B
| $6.51M | 0.01% |
195,848
-1,000,157
| -84% | -$31.1M |
|
|
DX
1604
Dynex Capital
DX
$3.2B
| $6.5M | 0.01% |
309,246
+201,556
| +187% | +$4.32M |
|
1605
Duke Energy
DUK
$95.1B
| $6.49M | 0.01% |
+77,128
| New | +$6.74M |
|
1606
CALL
Alcoa
AA
$13.1B
| $6.46M | 0.01% |
+120,000
| New | +$5.49M |
|
|
RVNC
1607
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.46M | 0.01% |
+180,800
| New | +$5.19M |
|
|
CUDA
1608
DELISTED
Barracuda Networks, Inc.
CUDA
| $6.46M | 0.01% |
234,863
+107,519
| +84% | +$2.67M |
|
1609
Wabtec
WAB
$50.8B
| $6.45M | 0.01% |
79,255
+56,557
| +249% | +$4.32M |
|
1610
CALL
Mondelez International
MDLZ
$80.7B
| $6.42M | 0.01% |
150,000
-152,000
| -50% | -$6.38M |
|
1611
CALL
The Mosaic Company
MOS
$7.77B
| $6.42M | 0.01% |
250,000
+210,000
| +525% | +$4.83M |
|
1612
CALL
Qualcomm
QCOM
$174B
| $6.4M | 0.01% |
+100,000
| New | +$6.06M |
|
1613
Ryman Hospitality Properties
RHP
$8.97B
| $6.4M | 0.01% |
92,678
+36,935
| +66% | +$2.47M |
|
1614
Zillow
Z
$7.92B
| $6.38M | 0.01% |
+155,842
| New | +$6.41M |
|
1615
Unifirst Corp
UNF
$5.21B
| $6.38M | 0.01% |
38,660
+32,134
| +492% | +$5.12M |
|
|
WW
1616
DELISTED
WW International
WW
| $6.37M | 0.01% |
143,879
-39,804
| -22% | -$1.81M |
|
1617
Celldex Therapeutics
CLDX
$3.17B
| $6.37M | 0.01% |
149,435
+26,731
| +22% | +$1.15M |
|
1618
Cirrus Logic
CRUS
$5.57B
| $6.37M | 0.01% |
122,751
-175,435
| -59% | -$9.48M |
|
1619
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.8B
| $6.37M | 0.01% |
75,000
-25,000
| -25% | -$2.09M |
|
|
SCMP
1620
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $6.36M | 0.01% |
354,276
-424,795
| -55% | -$5.23M |
|
1621
Dorman Products
DORM
$3.83B
| $6.35M | 0.01% |
+103,849
| New | +$7.04M |
|
1622
Adient
ADNT
$1.44B
| $6.34M | 0.01% |
80,590
+36,853
| +84% | +$2.97M |
|
1623
KT
KT
$9.34B
| $6.34M | 0.01% |
405,898
-626,386
| -61% | -$9.22M |
|
|
HOLI
1624
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $6.33M | 0.01% |
284,122
+241,930
| +573% | +$5.58M |
|
|
DQ
1625
Daqo New Energy
DQ
$908M
| $6.32M | 0.01% |
+531,700
| New | +$4.54M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.